June 17, 2026
High Tide Inc.
ISIN: CA42981E4013
High Tide’s German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026
CALGARY, AB, June 17, 2026 – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across...
Read more >>High Tide Welcomes Historic Executive Order on Cannabis Rescheduling and Medicare Reimbursements for CBD Products
The Company confirms it is assessing U.S. licensing pathways for its Canna Cabana retail brand NuLeaf Naturals and FAB CBD evaluating Medicare-aligned product categories CALGARY, AB, December 18, 2025 – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world...
Read more >High Tide to Open Three New Canna Cabana Locations
CALGARY, AB, December 05, 2025 – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it will open three new Canna Cabana branded locations across Ontario and Alberta,...
Read more >High Tide Opens First European Canna Cabana in Berlin
The Company Becomes First Publicly Traded North American Cannabis Operator to Setup Bricks-and-Mortar Presence in Europe’s Largest Cannabis Market CALGARY, AB, December 1, 2025 – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component...
Read more >